Both Clover Health Investments (NASDAQ: CLOV) and Senseonics Holdings (NYSEMKT: SENS) have emerged as meme stocks over the last few months. Senseonics has been the much bigger winner so far, but that doesn't necessarily mean it will continue to outperform Clover Health going forward. In this Motley Fool Live video recorded on July 7, Motley Fool contributors Keith Speights and Brian Orelli discuss which of these two meme stocks is the better pick right now.
Shares of Senseonics Holdings (NYSEMKT: SENS) skyrocketed 340% in the first half of 2021. One key early catalyst for Senseonics was a positive coverage decision in January by health insurer EmblemHealth for the Eversense continuous glucose-monitoring (CGM) system used by individuals with diabetes. In June, Senseonics reported positive results from a clinical study of its version of the Eversense device that can remain implanted for 180 days.
GERMANTOWN, Md., July 02, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan (the "Plan") in accordance with NYSE American Company Guide Section 711(a).